BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22973452)

  • 1. Human anti-CCR4 minibody gene transfer for the treatment of cutaneous T-cell lymphoma.
    Han T; Abdel-Motal UM; Chang DK; Sui J; Muvaffak A; Campbell J; Zhu Q; Kupper TS; Marasco WA
    PLoS One; 2012; 7(9):e44455. PubMed ID: 22973452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
    Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fully human antagonistic antibodies against CCR4 potently inhibit cell signaling and chemotaxis.
    Hagemann UB; Gunnarsson L; Géraudie S; Scheffler U; Griep RA; Reiersen H; Duncan AR; Kiprijanov SM
    PLoS One; 2014; 9(7):e103776. PubMed ID: 25080123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs.
    Wang Z; Ramakrishna R; Wang Y; Qiu Y; Ma J; Mintzlaff D; Zhang H; Li B; Hammell B; Lucia MS; Pomfret E; Su AA; Washington KM; Mathes DW; Wang Z
    Eur J Pharmacol; 2024 Apr; 968():176408. PubMed ID: 38367684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV8 virions hijack serum proteins to increase hepatocyte binding for transduction enhancement.
    Pei X; He T; Hall NE; Gerber D; Samulski RJ; Li C
    Virology; 2018 May; 518():95-102. PubMed ID: 29455066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments.
    Zengarini C; Guglielmo A; Mussi M; Motta G; Agostinelli C; Sabattini E; Piraccini BM; Pileri A
    Antibodies (Basel); 2024 Apr; 13(2):. PubMed ID: 38804300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral Vectors in Gene Therapy: Where Do We Stand in 2023?
    Lundstrom K
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression profile of human T cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodies.
    Sousa IG; Simi KCR; do Almo MM; Bezerra MAG; Doose G; Raiol T; Stadler PF; Hoffmann S; Maranhão AQ; Brigido MM
    BMC Genomics; 2019 Jul; 20(1):593. PubMed ID: 31324145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.
    Lefrançois P; Xie P; Wang L; Tetzlaff MT; Moreau L; Watters AK; Netchiporouk E; Provost N; Gilbert M; Ni X; Sasseville D; Wheeler DA; Duvic M; Litvinov IV
    Oncoimmunology; 2018; 7(8):e1467856. PubMed ID: 30221071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.
    Cuesta-Mateos C; Alcaraz-Serna A; Somovilla-Crespo B; Muñoz-Calleja C
    Front Immunol; 2017; 8():1936. PubMed ID: 29387053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Dysregulated Cytokine Signaling and Bacterial Triggers in the Pathogenesis of Cutaneous T-Cell Lymphoma.
    Fanok MH; Sun A; Fogli LK; Narendran V; Eckstein M; Kannan K; Dolgalev I; Lazaris C; Heguy A; Laird ME; Sundrud MS; Liu C; Kutok J; Lacruz RS; Latkowski JA; Aifantis I; Ødum N; Hymes KB; Goel S; Koralov SB
    J Invest Dermatol; 2018 May; 138(5):1116-1125. PubMed ID: 29128259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TruSeq-Based Gene Expression Analysis of Formalin-Fixed Paraffin-Embedded (FFPE) Cutaneous T-Cell Lymphoma Samples: Subgroup Analysis Results and Elucidation of Biases from FFPE Sample Processing on the TruSeq Platform.
    Lefrançois P; Tetzlaff MT; Moreau L; Watters AK; Netchiporouk E; Provost N; Gilbert M; Ni X; Sasseville D; Duvic M; Litvinov IV
    Front Med (Lausanne); 2017; 4():153. PubMed ID: 29018799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State of play and clinical prospects of antibody gene transfer.
    Hollevoet K; Declerck PJ
    J Transl Med; 2017 Jun; 15(1):131. PubMed ID: 28592330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CCR4 monoclonal antibody enhances antitumor immunity by modulating tumor-infiltrating Tregs in an ovarian cancer xenograft humanized mouse model.
    Chang DK; Peterson E; Sun J; Goudie C; Drapkin RI; Liu JF; Matulonis U; Zhu Q; Marasco WA
    Oncoimmunology; 2016 Mar; 5(3):e1090075. PubMed ID: 27141347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized mouse G6 anti-idiotypic monoclonal antibody has therapeutic potential against IGHV1-69 germline gene-based B-CLL.
    Chang DK; Kurella VB; Biswas S; Avnir Y; Sui J; Wang X; Sun J; Wang Y; Panditrao M; Peterson E; Tallarico A; Fernandes S; Goodall M; Zhu Q; Brown JR; Jefferis R; Marasco WA
    MAbs; 2016; 8(4):787-98. PubMed ID: 26963739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel delivery approaches for cancer therapeutics.
    Mitra AK; Agrahari V; Mandal A; Cholkar K; Natarajan C; Shah S; Joseph M; Trinh HM; Vaishya R; Yang X; Hao Y; Khurana V; Pal D
    J Control Release; 2015 Dec; 219():248-268. PubMed ID: 26456750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering humoral immunity as prophylaxis or therapy.
    Deal CE; Balazs AB
    Curr Opin Immunol; 2015 Aug; 35():113-22. PubMed ID: 26183209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).
    Litvinov IV; Netchiporouk E; Cordeiro B; Doré MA; Moreau L; Pehr K; Gilbert M; Zhou Y; Sasseville D; Kupper TS
    Clin Cancer Res; 2015 Jun; 21(12):2820-9. PubMed ID: 25779945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges.
    Vela M; Aris M; Llorente M; Garcia-Sanz JA; Kremer L
    Front Immunol; 2015; 6():12. PubMed ID: 25688243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus-mediated cancer gene therapy: current status.
    Luo J; Luo Y; Sun J; Zhou Y; Zhang Y; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt B):347-56. PubMed ID: 25444906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.